Novo Nordisk (NVO) Profit Margin (2006 - 2026)
Novo Nordisk (NVO) profit margin from Mar 31, 2006 to Mar 31, 2026. The current Novo Nordisk (NVO) profit margin is 50.15%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Novo Nordisk (NVO)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 33.14% | -4.69% |
| 2024 | 34.78% | -3.48% |
| 2023 | 36.03% | +14.82% |
| 2022 | 31.38% | -7.49% |
| 2021 | 33.92% | +2.18% |
| 2020 | 33.19% | +3.99% |
| 2019 | 31.92% | -7.58% |
| 2018 | 34.54% | +1.18% |
| 2017 | 34.14% | +0.62% |
| 2016 | 33.93% | +5.04% |
| 2015 | 32.30% | +8.32% |
| 2014 | 29.82% | -1.05% |
| 2013 | 30.13% | +9.71% |
| 2012 | 27.47% | +6.59% |
| 2011 | 25.77% | +8.74% |
| 2010 | 23.70% | +12.41% |
| 2009 | 21.08% | -0.40% |
| 2008 | 21.17% | +3.88% |
| 2007 | 20.38% | +22.36% |
| 2006 | 16.65% | N/A |
Comparison Novo Nordisk (NVO) profit margin with competitors
Novo Nordisk (NVO) profit margin is 50.15%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 37.36% | -25.50% |
| GILD | Gilead Sciences Inc | 29.04% | -42.09% |
| BMY | Bristol-Myers Squibb Company | 23.30% | -53.54% |
| GSK | GSK Plc | 22.77% | -54.60% |
| JNJ | Johnson & Johnson | 21.76% | -56.61% |
| AMGN | AMGEN Inc | 21.11% | -57.91% |
| AZN | Astrazeneca plc | 20.15% | -59.82% |
| PFE | Pfizer Inc | 18.59% | -62.93% |
| SNY | Sanofi | 14.35% | -71.39% |
| BIIB | Biogen Inc | 12.89% | -74.30% |
| OGN | Organon & Company | 10.00% | -80.06% |
| ABBV | Abbvie Inc | 4.63% | -90.77% |
| GRFS | Grifols SA | 4.29% | -91.45% |